false
OasisLMS
Login
Catalog
Compass Opioid Stewardship 2026 Virtual Symposium- ...
2026 OPPS Symposium Video
2026 OPPS Symposium Video
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The transcript captures a virtual COMPASS clinician conference on chronic pain management. The agenda includes an overview of 2026 pain-care challenges, literature updates, practical “quick-hit” sessions, and roundtable discussion. The opening lecture reviews a tougher prescribing environment: opioid prescribing has dropped >50% since 2012, fewer clinicians accept chronic opioid patients, and legal/board scrutiny has increased. The speaker emphasizes that both reckless prescribing and abrupt opioid dose cuts can trigger serious legal consequences and patient harm. Pharmacy refusals and shortages are also common; COMPASS provides step-by-step tools for navigating pharmacy barriers.<br /><br />Using a complex case (older patient on high-dose opioids plus benzodiazepines and gabapentin), the speaker outlines a structured onboarding approach: long first visit focused on listening and safety basics (PDMP, agreements, urine drug testing, naloxone), followed by a second visit emphasizing pain education (nociception vs pain vs suffering; nociceptive/neuropathic/nociplastic pain) and multimodal care (sleep, movement, knowledge, psychology, medication review). Risk stratification should guide visit frequency and monitoring. Aberrancies (e.g., early refills, unexpected tox results, overdose) require consistent, compassionate “aberrancy management,” including considering buprenorphine and treating substance use disorder rather than patient abandonment.<br /><br />A literature review highlights: limited benefit and meaningful harms with tramadol; potential cognitive risks with repeated gabapentin exposure; durable benefits from CBT, mindfulness, lifestyle change, acupressure, and walking for low back pain; mixed harms of continuing vs tapering long-term opioids; telehealth CBT effectiveness; modest gains from EHR decision support; and possible opioid-sparing effects of regulated medical cannabis programs.<br /><br />Quick sessions cover osteopathic/manual techniques, AI scribes and evidence tools, COMPASS resources, medical board risk, buprenorphine prescribing/rotations, trauma/ACEs and pain sensitization, and benzodiazepine tapering principles emphasizing slow, individualized, shared decision-making.
Keywords
chronic pain management
COMPASS clinician conference
opioid prescribing challenges 2026
opioid tapering risks
PDMP monitoring
urine drug testing
naloxone co-prescribing
pharmacy refusals and shortages
multimodal pain care
nociceptive neuropathic nociplastic pain
aberrancy management
buprenorphine rotation
benzodiazepine tapering
CBT and mindfulness for pain
gabapentin and tramadol safety
×
Please select your language
1
English